Cross Staff Investments’s Merck MRK Stock Holding History

Cross Staff Investments’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$951K	Hold	7,397	–	–	0.54%	47
2026 Q1	$890K	Hold	7,397	–	–	0.45%	47
2025 Q4	$779K	Hold	7,397	–	–	0.43%	53
2025 Q3	$621K	Sell	7,397 -1	-0%	-$82	0.43%	69
2025 Q2	$586K	Hold	7,398	–	–	0.44%	68
2025 Q1	$664K	Hold	7,398	–	–	0.5%	58
2024 Q4	$736K	Buy	7,398 +490	+7%	+$50.5K	0.51%	46
2024 Q3	$784K	Buy	6,908 +133	+2%	+$15.8K	0.61%	45
2024 Q2	$839K	Buy	6,775 +65	+1%	+$8.37K	0.7%	43
2024 Q1	$885K	Hold	6,710	–	–	0.75%	42
2023 Q4	$732K	Buy	6,710 +225	+3%	+$23.4K	0.65%	45
2023 Q3	$668K	Hold	6,485	–	–	0.65%	44
2023 Q2	$748K	Sell	6,485 -600	-8%	-$68.1K	0.69%	42
2023 Q1	$754K	Hold	7,085	–	–	0.75%	39
2022 Q4	$786K	Hold	7,085	–	–	0.82%	36
2022 Q3	$610K	Hold	7,085	–	–	0.68%	42
2022 Q2	$646K	Hold	7,085	–	–	0.71%	45
2022 Q1	$581K	Hold	7,085	–	–	0.54%	54
2021 Q4	$543K	Buy	+7,085	New	+$564K	0.49%	62

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cross Staff Investments's MRK Position: Q2 2026 in Review

Cross Staff Investments held its Merck (MRK) position steady in Q2 2026 at 7,397 shares worth $951K. The position accounts for 0.54% of the portfolio, ranked #47.

Cross Staff Investments first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Cross Staff Investments held 7,397 shares of Merck worth $951K as of Q2 2026.
Cross Staff Investments left its Merck share count unchanged in Q2 2026.
Merck made up 0.54% of Cross Staff Investments's portfolio in Q2 2026, its #47 holding.
Cross Staff Investments first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.